Live Nasdaq Composite: Chip Stocks Buckle Under Capex Pressure as Markets Hunt Leadership

Investing

AbbVie : ABBV

All AbbVie Articles

613 Articles

Lee Jackson | Apr 28, 2022 at 7:15 AM EDT

7 ‘Strong Buy’ Dividend Kings to Move to Fast in Case of Total Market Meltdown

Any company that has paid rising dividends for 50 years or more is the epitome of safe and dependable. These…

Paul Ausick | Apr 27, 2022 at 12:03 PM EDT

Earnings Previews: AbbVie, AstraZeneca, Bristol-Meyers Squibb

Here are previews of three pharmaceutical giants set to report earnings before markets open on Friday.

Lee Jackson | Apr 13, 2022 at 8:58 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: AbbVie, Blackstone, Boston Scientific, CarMax, Chewy, Eli Lilly, Medtronic, Shopify, Veru and More

Wednesday's top analyst upgrades and downgrades included AbbVie, Blackstone, Boston Scientific, CarMax, Chewy, Eli Lilly, Medtronic, NetApp, Ping Identity, Shopify,…

Chris Lange | Apr 6, 2022 at 3:25 PM EDT

New Era of the Activist Investor, and More Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, JetBlue and More

Wednesday’s additional top analyst upgrades and downgrades included AbbVie, Bristol-Myers, JetBlue, and more.

Lee Jackson | Mar 29, 2022 at 7:27 AM EDT

6 ‘Strong Buy’ Highest-Yielding Dividend Kings Are Incredible Q2 Ideas

These six Dividend Kings make sense for growth and income investors looking for safety and dependability in these turbulent times.…

Lee Jackson | Mar 18, 2022 at 7:26 AM EDT

Fund Managers Pile Into Big Dividend Health Care Stocks: 8 ‘Strong Buy’ Winners

A recent survey of global fund managers found that many have turned to health care for some stability in these…

Lee Jackson | Mar 2, 2022 at 7:21 AM EST

5 Warren Buffett Stocks Are Very Safe Buys Now and Pay Big Dependable Dividends

These five Warren Buffett top stock picks are ideal for growth and income investors to consider now, especially in what…

Chris Lange | Mar 1, 2022 at 6:48 AM EST

3 Biopharma Stocks That Analysts Have Grown Bearish On

Here are a few big biopharma names on which Wall Street is growing more bearish.

Lee Jackson | Feb 28, 2022 at 8:52 AM EST

Monday’s Top Analyst Upgrades and Downgrades: AbbVie, Alibaba, Best Buy, Block, Coinbase, Foot Locker, Home Depot, Nvidia, Under Armour, Virgin Galactic and More

Monday's top analyst upgrades and downgrades included AbbVie, Alcoa, Alibaba, Best Buy, Beyond Meat, Block, Coinbase Global, Foot Locker, GoPro,…

Chris Lange | Feb 3, 2022 at 3:51 PM EST

Thursday Afternoon’s Top Analyst Upgrades and Downgrades: AbbVie, First Solar, The Gap, Qualcomm, Spotify and More

Thursday afternoon's top analyst upgrades and downgrades included AbbVie, First Solar, The Gap, Qualcomm, Spotify and more.

Paul Ausick | Jan 31, 2022 at 1:27 PM EST

Earnings Previews: AbbVie, Humana, Marathon Petroleum, Novartis

We have previewed here three big health care companies, along with the country's largest oil refiner and marketer.

Lee Jackson | Jan 14, 2022 at 8:55 AM EST

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Chipotle, Costco, Ford, Riot Blockchain, Southwest Air, United Airlines, Walmart and More

Friday's top analyst upgrades and downgrades included AbbVie, Chipotle Mexican Grill, Costco Wholesale, Crocs, Dominion Energy, Enphase Energy, Ford, Hertz,…

Chris Lange | Jan 12, 2022 at 3:08 PM EST

Wednesday Afternoon Analyst Upgrades and Downgrades: AbbVie, Biogen, DoorDash, Kratos Defense, PayPal and More

Wednesday afternoon's top analyst upgrades and downgrades included AbbVie, Biogen, DoorDash, Kratos Defense, PayPal and more.

Lee Jackson | Dec 29, 2021 at 7:26 AM EST

5 High-Yielding Dividend Aristocrats Are ‘Strong Buy’ Stock Ideas for 2022

These five Dividend Aristocrats are in sectors that have underperformed in 2021 or are solid plays as investors continue to…

Chris Lange | Dec 9, 2021 at 11:50 AM EST

Thursday Afternoon’s Analyst Upgrades and Downgrades: AbbVie, Occidental Petroleum, Pfizer, Yum! Brands and More

Thursday afternoon's top analyst upgrades and downgrades included AbbVie, Allstate, Amgen, Occidental Petroleum, Pfizer, SunPower, Twilio and Yum! Brands.

1 … 11 12 13 14 15 … 41

AbbVie : ABBV

All AbbVie Articles

7 ‘Strong Buy’ Dividend Kings to Move to Fast in Case of Total Market Meltdown

Earnings Previews: AbbVie, AstraZeneca, Bristol-Meyers Squibb

Wednesday’s Top Analyst Upgrades and Downgrades: AbbVie, Blackstone, Boston Scientific, CarMax, Chewy, Eli Lilly, Medtronic, Shopify, Veru and More

New Era of the Activist Investor, and More Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, JetBlue and More

6 ‘Strong Buy’ Highest-Yielding Dividend Kings Are Incredible Q2 Ideas

Fund Managers Pile Into Big Dividend Health Care Stocks: 8 ‘Strong Buy’ Winners

5 Warren Buffett Stocks Are Very Safe Buys Now and Pay Big Dependable Dividends

3 Biopharma Stocks That Analysts Have Grown Bearish On

Monday’s Top Analyst Upgrades and Downgrades: AbbVie, Alibaba, Best Buy, Block, Coinbase, Foot Locker, Home Depot, Nvidia, Under Armour, Virgin Galactic and More

Thursday Afternoon’s Top Analyst Upgrades and Downgrades: AbbVie, First Solar, The Gap, Qualcomm, Spotify and More

Earnings Previews: AbbVie, Humana, Marathon Petroleum, Novartis

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Chipotle, Costco, Ford, Riot Blockchain, Southwest Air, United Airlines, Walmart and More

Wednesday Afternoon Analyst Upgrades and Downgrades: AbbVie, Biogen, DoorDash, Kratos Defense, PayPal and More

5 High-Yielding Dividend Aristocrats Are ‘Strong Buy’ Stock Ideas for 2022

Thursday Afternoon’s Analyst Upgrades and Downgrades: AbbVie, Occidental Petroleum, Pfizer, Yum! Brands and More

Live Nasdaq Composite: Chip Stocks Buckle Under Capex Pressure as Markets Hunt Leadership

Live: Will Intuitive Surgical Smash Tonight’s Q2 Earnings After 29% YTD Decline?

Live: Will Netflix’s Q2 Earnings Tonight Spark a Rebound for the Stock?

XRP Price Prediction: Can XRP Hit Double Digits?

A 70-Year-Old With $600,000 Delays Social Security for the 8% Bonus, and Walks Into a Bigger RMD

IRMAA Isn’t a Tax, but a Retired Couple Can Pay $8,000+ a Year Extra for the Same Medicare

A 70-Year-Old With $600,000 Delays Social Security for the 8% Bonus, and Walks Into a Bigger RMD

IRMAA Isn't a Tax, but a Retired Couple Can Pay $8,000+ a Year Extra for the Same Medicare

XRP Price Prediction: Can XRP Hit Double Digits?

A 70-Year-Old With $600,000 Delays Social Security for the 8% Bonus, and Walks Into a Bigger RMD

AbbVie : ABBV

All AbbVie Articles

7 ‘Strong Buy’ Dividend Kings to Move to Fast in Case of Total Market Meltdown

Earnings Previews: AbbVie, AstraZeneca, Bristol-Meyers Squibb

Wednesday’s Top Analyst Upgrades and Downgrades: AbbVie, Blackstone, Boston Scientific, CarMax, Chewy, Eli Lilly, Medtronic, Shopify, Veru and More

New Era of the Activist Investor, and More Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, JetBlue and More

6 ‘Strong Buy’ Highest-Yielding Dividend Kings Are Incredible Q2 Ideas

Fund Managers Pile Into Big Dividend Health Care Stocks: 8 ‘Strong Buy’ Winners

5 Warren Buffett Stocks Are Very Safe Buys Now and Pay Big Dependable Dividends

3 Biopharma Stocks That Analysts Have Grown Bearish On

Monday’s Top Analyst Upgrades and Downgrades: AbbVie, Alibaba, Best Buy, Block, Coinbase, Foot Locker, Home Depot, Nvidia, Under Armour, Virgin Galactic and More

Thursday Afternoon’s Top Analyst Upgrades and Downgrades: AbbVie, First Solar, The Gap, Qualcomm, Spotify and More

Earnings Previews: AbbVie, Humana, Marathon Petroleum, Novartis

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Chipotle, Costco, Ford, Riot Blockchain, Southwest Air, United Airlines, Walmart and More

Wednesday Afternoon Analyst Upgrades and Downgrades: AbbVie, Biogen, DoorDash, Kratos Defense, PayPal and More

5 High-Yielding Dividend Aristocrats Are ‘Strong Buy’ Stock Ideas for 2022

Thursday Afternoon’s Analyst Upgrades and Downgrades: AbbVie, Occidental Petroleum, Pfizer, Yum! Brands and More

Live Nasdaq Composite: Chip Stocks Buckle Under Capex Pressure as Markets Hunt Leadership

Live: Will Intuitive Surgical Smash Tonight’s Q2 Earnings After 29% YTD Decline?

Live: Will Netflix’s Q2 Earnings Tonight Spark a Rebound for the Stock?

XRP Price Prediction: Can XRP Hit Double Digits?

A 70-Year-Old With $600,000 Delays Social Security for the 8% Bonus, and Walks Into a Bigger RMD

IRMAA Isn’t a Tax, but a Retired Couple Can Pay $8,000+ a Year Extra for the Same Medicare

Featured Reads

A 70-Year-Old With $600,000 Delays Social Security for the 8% Bonus, and Walks Into a Bigger RMD

IRMAA Isn't a Tax, but a Retired Couple Can Pay $8,000+ a Year Extra for the Same Medicare